Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Dec 16;137(2):10.1007/s10549-012-2373-1. doi: 10.1007/s10549-012-2373-1

Table 2.

Association between PTP1B expression and clinicopatho-logical parameters

Clinicopathologic parameter PTP1B- positive PTP1B- negative Spearman's ρ p value
Mean tumor size (mm) 30.6 30.7 0.019 0.4797
Mean age at diagnosis (years) 63.1 63.8 –0.029 0.3159
n (%) n (%) Spearman's ρ p value
Tumor stage 0.017 0.6283
    pT1 178 (46.2) 207 (53.7)
    pT2 371 (50.3) 367 (49.7)
    pT3 52 (48.6) 55 (51.4)
    pT4 82 (47.7) 90 (52.3)
Tumor grade –0.018 0.4753
    1 157 (48.5) 167 (51.5)
    2 291 (50.5) 285 (49.5)
    3 235 (46.8) 267 (53.2)
Lymph node stage –0.026 0.6210
    pN0 363 (50.1) 362 (49.9)
    pN1 257 (47.6) 283 (52.4)
    pN2 63 (47.0) 71 (52.9)
Estrogen receptor –0.066 0.0137
    ER+ 527 (50.7) 513 (49.3)
    ER 153 (43.1) 202 (56.9)
HER2 –0.044 0.0985
    HER2+ 142 (53.1) 125 (46.8)
    HER2 537 (47.5) 592 (52.4)